McDonald Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$978K Buy
+9,457
New +$844K 0.24% 103
2024
Q1
Sell
-19,327
Closed -$1.53M 243
2023
Q4
$1.53M Sell
19,327
-10,325
-35% -$735K 0.45% 65
2023
Q3
$2.07M Buy
29,652
+4,640
+19% +$329K 0.67% 41
2023
Q2
$1.73M Sell
25,012
-847
-3% -$60.3K 0.53% 54
2023
Q1
$1.92M Sell
25,859
-4,591
-15% -$385K 0.62% 46
2022
Q4
$2.84M Sell
30,450
-277
-0.9% -$26.7K 0.97% 27
2022
Q3
$2.93M Sell
30,727
-24,432
-44% -$2.42M 1.12% 20
2022
Q2
$5.11M Buy
55,159
+3,551
+7% +$347K 1.3% 14
2022
Q1
$5.22M Buy
+51,608
New +$5.42M 1.14% 16
2021
Q4
Sell
-47,953
Closed -$4.07M 586
2021
Q3
$4.07M Sell
47,953
-1,858
-4% -$156K 0.96% 24
2021
Q2
$4.16M Buy
49,811
+1,863
+4% +$153K 0.98% 19
2021
Q1
$3.61M Buy
47,948
+4,713
+11% +$343K 0.93% 27
2020
Q4
$2.95M Buy
+43,235
New +$2.81M 0.83% 29

Other funds holding CVS

McDonald Partners's CVS Position: Q2 2026 in Review

McDonald Partners opened a new position in CVS Health (CVS) in Q2 2026: 9,457 shares worth $978K. The stake represents 0.24% of the portfolio and ranks #103 among its holdings. This is a return to the name: McDonald Partners previously reported a position in CVS as recently as Q4 2023.

McDonald Partners first reported a position in CVS in Q4 2020 and has held it in 13 quarters since. The position peaked at $5.22M in Q1 2022. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • McDonald Partners held 9,457 shares of CVS Health worth $978K as of Q2 2026.
  • CVS Health was a new McDonald Partners position in Q2 2026.
  • CVS Health made up 0.24% of McDonald Partners's portfolio in Q2 2026, its #103 holding.
  • McDonald Partners first reported a position in CVS Health in Q4 2020 and has held it in 13 quarters since.
  • McDonald Partners's CVS Health position peaked at $5.22M in Q1 2022.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on McDonald Partners's 13F filing for Q2 2026, filed 28 Jul 2026.